Home > Healthcare > Pharmaceuticals > Clinical Nutrition > U.S. Clinical Nutrition Market
U.S. infant clinical nutrition market size was over USD 6.5 billion in 2022. Increasing instances of premature births have increased the demand for infant nutrition products in the U.S. As per the CDC, in 2021, premature births affected 1 in every 10 infants in the country. The administration of clinical nutrition products in infants is known to offer metabolic and immunogenic support to prevent the risk of growth incapacities and abnormalities. Growing concerns related to infant nutrition have increased the demand for clinical nutrition products in the U.S.
U.S. clinical nutrition market size from metabolic disorders applications will be over USD 9 billion by 2032. Growing occurrence of metabolic disorders such as heart disease, type 2 diabetes, and others has increased the need for nutritional support in the country. Moreover, growing demand and awareness regarding the benefits offered by disease-specific clinical nutrition products in the precise management of various metabolic conditions is further working in favor of segment expansion.